{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T07:46:05Z","timestamp":1743579965943,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T00:00:00Z","timestamp":1445040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T00:00:00Z","timestamp":1445040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001172","name":"Hormel Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA172457","CA166011","R37 CA081064"],"award-info":[{"award-number":["CA172457","CA166011","R37 CA081064"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s10822-015-9877-9","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:26:02Z","timestamp":1445214362000},"page":"1045-1055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Statistical analysis of EGFR structures\u2019 performance in virtual screening"],"prefix":"10.1007","volume":"29","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zigang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,17]]},"reference":[{"key":"9877_CR1","doi-asserted-by":"publisher","first-page":"8225","DOI":"10.1021\/ja0709728","volume":"129","author":"KL Damm","year":"2007","unstructured":"Damm KL, Carlson HA (2007) Exploring experimental sources of multiple protein conformations in structure-based drug design. J Am Chem Soc 129:8225\u20138235","journal-title":"J Am Chem Soc"},{"key":"9877_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/prot.21214","volume":"66","author":"SY Huang","year":"2007","unstructured":"Huang SY, Zou XQ (2007) Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. Proteins 66:399\u2013421","journal-title":"Proteins"},{"key":"9877_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1021\/ci9003943","volume":"50","author":"M Rueda","year":"2010","unstructured":"Rueda M, Bottegoni G, Abagyan R (2010) Recipes for the selection of experimental protein conformations for virtual screening. J Chem Inf Model 50:186\u2013193","journal-title":"J Chem Inf Model"},{"key":"9877_CR4","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1021\/ci200257b","volume":"51","author":"Y Li","year":"2011","unstructured":"Li Y, Kim DJ, Ma WY, Lubet RA, Bode AM et al (2011) Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structures. J Chem Inf Model 51:2904\u20132914","journal-title":"J Chem Inf Model"},{"key":"9877_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1021\/ci3004557","volume":"53","author":"N Ben Nasr","year":"2013","unstructured":"Ben Nasr N, Guillemain H, Lagarde N, Zagury JF, Montes M (2013) Multiple structures for virtual ligand screening: defining binding site properties-based criteria to optimize the selection of the query. J Chem Inf Model 53:293\u2013311","journal-title":"J Chem Inf Model"},{"key":"9877_CR6","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1021\/ci5002026","volume":"54","author":"B Wang","year":"2014","unstructured":"Wang B, Buchman CD, Li L, Hurley TD, Meroueh SO (2014) Enrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2. J Chem Inf Model 54:2105\u20132116","journal-title":"J Chem Inf Model"},{"key":"9877_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/BJ20121513","volume":"448","author":"JH Park","year":"2012","unstructured":"Park JH, Liu Y, Ma Lemmon, Radhakrishnan R (2012) Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain. Biochem J 448:417\u2013423","journal-title":"Biochem J"},{"key":"9877_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.str.2012.11.014","volume":"21","author":"KS Gajiwala","year":"2013","unstructured":"Gajiwala KS, Feng JL, Ferre R, Ryan K, Brodsky O et al (2013) Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition. Structure\u00a021:209\u2013219","journal-title":"Structure"},{"key":"9877_CR9","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0709662105","volume":"105","author":"CH Yun","year":"2008","unstructured":"Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H et al (2008) The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci USA 105:2070\u20132075","journal-title":"Proc Natl Acad Sci USA"},{"key":"9877_CR10","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1021\/ct500162b","volume":"10","author":"Y Li","year":"2014","unstructured":"Li Y, Li X, Ma W, Dong Z (2014) Conformational transition pathways of epidermal growth factor receptor kinase domain from multiple molecular dynamics simulations and Bayesian clustering. J Chem Theory Comput 10:3503\u20133511","journal-title":"J Chem Theory Comput"},{"key":"9877_CR11","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1021\/ja003834q","volume":"123","author":"JM Wang","year":"2001","unstructured":"Wang JM, Morin P, Wang W, Kollman PA (2001) Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J Am Chem Soc 123:5221\u20135230","journal-title":"J Am Chem Soc"},{"key":"9877_CR12","doi-asserted-by":"publisher","first-page":"e1000528","DOI":"10.1371\/journal.pcbi.1000528","volume":"5","author":"N Okimoto","year":"2009","unstructured":"Okimoto N, Futatsugi N, Fuji H, Suenaga A, Morimoto G et al (2009) High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations. PLoS Comput Biol 5:e1000528","journal-title":"PLoS Comput Biol"},{"key":"9877_CR13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jcc.21372","volume":"31","author":"G Rastelli","year":"2010","unstructured":"Rastelli G, Del Rio A, Degliesposti G, Sgobba M (2010) Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J Comput Chem 31:797\u2013810","journal-title":"J Comput Chem"},{"key":"9877_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/minf.201100135","volume":"31","author":"N Homeyer","year":"2012","unstructured":"Homeyer N, Gohlke H (2012) Free energy calculations by the molecular mechanics Poisson\u2013Boltzmann surface area method. Mol Inf 31:114\u2013122","journal-title":"Mol Inf"},{"key":"9877_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461","journal-title":"Expert Opin Drug Discov"},{"key":"9877_CR16","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1021\/ci400025f","volume":"53","author":"KL Damm-Ganamet","year":"2013","unstructured":"Damm-Ganamet KL, Smith RD, Dunbar JB Jr, Stuckey JA, Carlson HA (2013) CSAR benchmark exercise 2011\u20132012: evaluation of results from docking and relative ranking of blinded congeneric series. J Chem Inf Model 53:1853\u20131870","journal-title":"J Chem Inf Model"},{"key":"9877_CR17","doi-asserted-by":"publisher","first-page":"46265","DOI":"10.1074\/jbc.M207135200","volume":"277","author":"J Stamos","year":"2002","unstructured":"Stamos J, Sliwkowski MX, Eigenbrot C (2002) Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 277:46265\u201346272","journal-title":"J Biol Chem"},{"key":"9877_CR18","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-04-1168","volume":"64","author":"ER Wood","year":"2004","unstructured":"Wood ER, Truesdale AT, McDonald OB, Yuan D, Hassell A et al (2004) A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. Cancer Res 64:6652\u20136659","journal-title":"Cancer Res"},{"key":"9877_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/onc.2012.21","volume":"32","author":"S Yoshikawa","year":"2013","unstructured":"Yoshikawa S, Kukimoto-Niino M, Parker L, Handa N, Terada T et al (2013) Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor. Oncogene 32:27\u201338","journal-title":"Oncogene"},{"key":"9877_CR20","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cell.2006.05.013","volume":"125","author":"X Zhang","year":"2006","unstructured":"Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J (2006) An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125:1137\u20131149","journal-title":"Cell"},{"key":"9877_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","volume":"11","author":"CH Yun","year":"2007","unstructured":"Yun CH, Boggon TJ, Li YQ, Woo MS, Greulich H et al (2007) Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell 11:217\u2013227","journal-title":"Cancer Cell"},{"key":"9877_CR22","first-page":"U713","volume":"450","author":"X Zhang","year":"2007","unstructured":"Zhang X, Pickin KA, Bose R, Jura N, Cole PA et al (2007) Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450:U713\u2013U741","journal-title":"Nature"},{"key":"9877_CR23","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1016\/j.bmcl.2008.07.020","volume":"18","author":"G Xu","year":"2008","unstructured":"Xu G, Abad MC, Connolly PJ, Neeper MP, Struble GT et al (2008) 4-amino-6-arylamino-pyrimidine-5-carbaldehyde hydrazones as potent ErbB-2\/EGFR dual kinase inhibitors. Bioorg Med Chem Lett 18:4615\u20134619","journal-title":"Bioorg Med Chem Lett"},{"key":"9877_CR24","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1016\/j.bmcl.2008.05.024","volume":"18","author":"G Xu","year":"2008","unstructured":"Xu G, Searle LL, Hughes TV, Beck AK, Connolly PJ et al (2008) Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases. Bioorg Med Chem Lett 18:3495\u20133499","journal-title":"Bioorg Med Chem Lett"},{"key":"9877_CR25","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2009.04.025","volume":"137","author":"N Jura","year":"2009","unstructured":"Jura N, Endres NF, Engel K, Deindl S, Das R et al (2009) Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137:1293\u20131307","journal-title":"Cell"},{"key":"9877_CR26","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.bmcl.2010.03.015","volume":"20","author":"SD Fidanze","year":"2010","unstructured":"Fidanze SD, Erickson SA, Wang GT, Mantei R, Clark RF et al (2010) Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases. Bioorg Med Chem Lett 20:2452\u20132455","journal-title":"Bioorg Med Chem Lett"},{"key":"9877_CR27","doi-asserted-by":"publisher","first-page":"18756","DOI":"10.1074\/jbc.M110.206193","volume":"286","author":"K Aertgeerts","year":"2011","unstructured":"Aertgeerts K, Skene R, Yano J, Sang B-C, Zou H et al (2011) Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. J Biol Chem 286:18756\u201318765","journal-title":"J Biol Chem"},{"key":"9877_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1021\/ml300327z","volume":"4","author":"S Sogabe","year":"2013","unstructured":"Sogabe S, Kawakita Y, Igaki S, Iwata H, Miki H et al (2013) Structure-based approach for the discovery of pyrrolo[3,2-d]pyrimidine-based EGFR T790M\/L858R mutant inhibitors. ACS Med Chem Lett 4:201\u2013205","journal-title":"ACS Med Chem Lett"},{"key":"9877_CR29","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.bmc.2013.02.014","volume":"21","author":"Y Kawakita","year":"2013","unstructured":"Kawakita Y, Seto M, Ohashi T, Tamura T, Yusa T et al (2013) Design and synthesis of novel pyrimido 4,5-b azepine derivatives as HER2\/EGFR dual inhibitors. Biorg Med Chem 21:2250\u20132261","journal-title":"Biorg Med Chem"},{"key":"9877_CR30","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1021\/jm400072p","volume":"56","author":"Y-H Peng","year":"2013","unstructured":"Peng Y-H, Shiao H-Y, Tu C-H, Liu P-M, Hsu JT-A et al (2013) Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors. J Med Chem 56:3889\u20133903","journal-title":"J Med Chem"},{"key":"9877_CR31","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1021\/jm400822z","volume":"56","author":"RA Ward","year":"2013","unstructured":"Ward RA, Anderton MJ, Ashton S, Bethel PA, Box M et al (2013) Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR). J Med Chem 56:7025\u20137048","journal-title":"J Med Chem"},{"key":"9877_CR32","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52:1757\u20131768","journal-title":"J Chem Inf Model"},{"key":"9877_CR33","unstructured":"Schr\u00f6dinger (2014) Maestro, version 9.8. LLC, New York"},{"key":"9877_CR34","unstructured":"R. The R project for statistical computing ( https:\/\/www.r-project.org\/ )"},{"key":"9877_CR35","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/jcc.10349","volume":"24","author":"Y Duan","year":"2003","unstructured":"Duan Y, Wu C, Chowdhury S, Lee MC, Xiong GM et al (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 24:1999\u20132012","journal-title":"J Comput Chem"},{"key":"9877_CR36","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"JM Wang","year":"2004","unstructured":"Wang JM, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174","journal-title":"J Comput Chem"},{"key":"9877_CR37","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926\u2013935","journal-title":"J Chem Phys"},{"key":"9877_CR38","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, G\u00f6tz AW, Poole D, Le Grand S, Walker RC (2013) Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. J Chem Theory Comput 9:3878\u20133888","journal-title":"J Chem Theory Comput"},{"key":"9877_CR39","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case DA, Cheatham TE, Darden T, Gohlke H, Luo R et al (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668\u20131688","journal-title":"J Comput Chem"},{"key":"9877_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"JP Ryckaert","year":"1977","unstructured":"Ryckaert JP, Ciccotti G, Berendsen HJC (1977) Numerical-integration of cartesian equations of motion of a system with constraints\u2014molecular-dynamics of n-alkanes. J Comput Phys 23:327\u2013341","journal-title":"J Comput Phys"},{"key":"9877_CR41","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H et al (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577\u20138593","journal-title":"J Chem Phys"},{"key":"9877_CR42","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H et al (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8:3314\u20133321","journal-title":"J Chem Theory Comput"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-015-9877-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9877-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T21:33:01Z","timestamp":1718141581000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-015-9877-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,17]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["9877"],"URL":"https:\/\/doi.org\/10.1007\/s10822-015-9877-9","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2015,10,17]]},"assertion":[{"value":"4 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}